| 出品公司: | ZYbscience |
|---|---|
| 载体名称: | pACYC177 |
| 质粒类型: | 大肠杆菌克隆载体 |
| 高拷贝/低拷贝: | -- |
| 启动子: | -- |
| 克隆方法: | 多克隆位点,限制性内切酶 |
| 载体大小: | 3941bp |
| 5' 测序引物及序列: | -- |
| 3' 测序引物及序列: | -- |
| 载体标签: | -- |
| 载体抗性: | Ampicillin |
| 筛选标记: | -- |
| 备注: | -- |
| 产品目录号: | ZY37031 |
| 稳定性: | -- |
| 组成型: | -- |
| 病毒/非病毒: | 非病毒 |
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
-20℃低温保存
- 保质期:
三年
- 英文名:
pACYC177
- 库存:
20
- 供应商:
泽叶生物
载体基本信息
载体质粒图谱和多克隆位点信息
载体简介
pACYC177 is an E. coli plasmid cloning vector containing the p15A origin of replication (1-4). This allows pACYC177 to coexist in cells with plasmids of the ColE1 compatibility group (e.g., pBR322, pUC19). It is a low copy number vector, at about 15 copies per cell (5), but can be amplified with chloramphenicol or spectinomycin.
Enzymes with unique restriction sites are shown in bold type and enzymes with two restriction sites are shown in regular type. Location of sites of all NEB restriction enzymes can be found on the NEB web site (choose Technical Reference > DNA Sequences and Maps). Restriction site coordinates refer to the position of the 5′-most base on the top strand in each recognition sequence.
载体序列
LOCUS pACYC177 3941 bp DNA SYN
DEFINITION pACYC177
ACCESSION
KEYWORDS
SOURCE
ORGANISM other sequences; artificial sequences; vectors.
FEATURES Location/Qualifiers
source 1..3941
/organism="pACYC177"
/mol_type="other DNA"
gene 10..618
/label="Ampicillin (252 - 860)"
/gene="Ampicillin (252 - 860)"
CDS 100..618
/label="ORF frame 1"
/translation="MTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVT
RLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAG
PLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAEIGASLIKHW*"
rep_origin complement(767..1595)
/label="p15A_origin"
/translation="MTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVT
RLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAG
PLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAEIGASLIKHW*"
gene 1923..2738
/label="KanR2"
/gene="KanR2"
/translation="MTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVT
RLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAG
PLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAEIGASLIKHW*"
CDS 1923..2738
/label="ORF frame 3"
/translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
misc_feature 3025..3515
/label="Tn3R"
/translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
promoter 3629..3657
/label="AmpR_promoter"
/translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
gene 3699..618
/label="Ampicillin"
/gene="Ampicillin"
/translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
CDS 3699..618
/label="ORF frame 3"
/translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGY
IELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVE
YSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRL
DRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPL
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIA
EIGASLIKHW*"
ORIGIN
1 gttgacgccg ggcaagagca actcggtcgc cgcatacact attctcagaa tgacttggtt
61 gagtactcac cagtcacaga aaagcatctt acggatggca tgacagtaag agaattatgc
121 agtgctgcca taaccatgag tgataacact gcggccaact tacttctgac aacgatcgga
181 ggaccgaagg agctaaccgc ttttttgcac aacatggggg atcatgtaac tcgccttgat
241 cgttgggaac cggagctgaa tgaagccata ccaaacgacg agcgtgacac cacgatgcct
301 gcagcaatgg caacaacgtt gcgcaaacta ttaactggcg aactacttac tctagcttcc
361 cggcaacaat taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg
421 gcccttccgg ctggctggtt tattgctgat aaatctggag ccggtgagcg tgggtctcgc
481 ggtatcattg cagcactggg gccagatggt aagccctccc gtatcgtagt tatctacacg
541 acggggagtc aggcaactat ggatgaacga aatagacaga tcgctgagat aggtgcctca
601 ctgattaagc attggtaact gtcagaccaa gtttactcat atatacttta gattgattta
661 aaacttcatt tttaatttaa aaggatctag gtgaagatcc tttttgataa tctcatgacc
721 aaaatccctt aacgtgagtt ttcgttccac tgagcgtcag accccttaat aagatgatct
781 tcttgagatc gttttggtct gcgcgtaatc tcttgctctg aaaacgaaaa aaccgccttg
841 cagggcggtt tttcgaaggt tctctgagct accaactctt tgaaccgagg taactggctt
901 ggaggagcgc agtcaccaaa acttgtcctt tcagtttagc cttaaccggc gcatgacttc
961 aagactaact cctctaaatc aattaccagt ggctgctgcc agtggtgctt ttgcatgtct
1021 ttccgggttg gactcaagac gatagttacc ggataaggcg cagcggtcgg actgaacggg
1081 gggttcgtgc atacagtcca gcttggagcg aactgcctac ccggaactga gtgtcaggcg
1141 tggaatgaga caaacgcggc cataacagcg gaatgacacc ggtaaaccga aaggcaggaa
1201 caggagagcg cacgagggag ccgccagggg gaaacgcctg gtatctttat agtcctgtcg
1261 ggtttcgcca ccactgattt gagcgtcaga tttcgtgatg cttgtcaggg gggcggagcc
1321 tatggaaaaa cggctttgcc gcggccctct cacttccctg ttaagtatct tcctggcatc
1381 ttccaggaaa tctccgcccc gttcgtaagc catttccgct cgccgcagtc gaacgaccga
1441 gcgtagcgag tcagtgagcg aggaagcgga atatatcctg tatcacatat tctgctgacg
1501 caccggtgca gccttttttc tcctgccaca tgaagcactt cactgacacc ctcatcagtg
1561 ccaacatagt aagccagtat acactccgct agcgctgagg tctgcctcgt gaagaaggtg
1621 ttgctgactc ataccaggcc tgaatcgccc catcatccag ccagaaagtg agggagccac
1681 ggttgatgag agctttgttg taggtggacc agttggtgat tttgaacttt tgctttgcca
1741 cggaacggtc tgcgttgtcg ggaagatgcg tgatctgatc cttcaactca gcaaaagttc
1801 gatttattca acaaagccac gttgtgtctc aaaatctctg atgttacatt gcacaagata
1861 aaaatatatc atcatgaaca ataaaactgt ctgcttacat aaacagtaat acaaggggtg
1921 ttatgagcca tattcaacgg gaaacgtctt gctcgaggcc gcgattaaat tccaacatgg
1981 atgctgattt atatgggtat aaatgggctc gcgataatgt cgggcaatca ggtgcgacaa
2041 tctatcgatt gtatgggaag cccgatgcgc cagagttgtt tctgaaacat ggcaaaggta
2101 gcgttgccaa tgatgttaca gatgagatgg tcagactaaa ctggctgacg gaatttatgc
2161 ctcttccgac catcaagcat tttatccgta ctcctgatga tgcatggtta ctcaccactg
2221 cgatccccgg gaaaacagca ttccaggtat tagaagaata tcctgattca ggtgaaaata
2281 ttgttgatgc gctggcagtg ttcctgcgcc ggttgcattc gattcctgtt tgtaattgtc
2341 cttttaacag cgatcgcgta tttcgtctcg ctcaggcgca atcacgaatg aataacggtt
2401 tggttgatgc gagtgatttt gatgacgagc gtaatggctg gcctgttgaa caagtctgga
2461 aagaaatgca taagcttttg ccattctcac cggattcagt cgtcactcat ggtgatttct
2521 cacttgataa ccttattttt gacgagggga aattaatagg ttgtattgat gttggacgag
2581 tcggaatcgc agaccgatac caggatcttg ccatcctatg gaactgcctc ggtgagtttt
2641 ctccttcatt acagaaacgg ctttttcaaa aatatggtat tgataatcct gatatgaata
2701 aattgcagtt tcatttgatg ctcgatgagt ttttctaatc agaattggtt aattggttgt
2761 aacactggca gagcattacg ctgacttgac gggacggcgg ctttgttgaa taaatcgaac
2821 ttttgctgag ttgaaggatc agatcacgca tcttcccgac aacgcagacc gttccgtggc
2881 aaagcaaaag ttcaaaatca ccaactggtc cacctacaac aaagctctca tcaaccgtgg
2941 ctccctcact ttctggctgg atgatggggc gattcaggcc tggtatgagt cagcaacacc
3001 ttcttcacga ggcagacctc agcgctcaaa gatgcagggg taaaagctaa ccgcatcttt
3061 accgacaagg catccggcag ttcaacagat cgggaagggc tggatttgct gaggatgaag
3121 gtggaggaag gtgatgtcat tctggtgaag aagctcgacc gtcttggccg cgacaccgcc
3181 gacatgatcc aactgataaa agagtttgat gctcagggtg tagcggttcg gtttattgac
3241 gacgggatca gtaccgacgg tgatatgggg caaatggtgg tcaccatcct gtcggctgtg
3301 gcacaggctg aacgccggag gatcctagag cgcacgaatg agggccgaca ggaagcaaag
3361 ctgaaaggaa tcaaatttgg ccgcaggcgt accgtggaca ggaacgtcgt gctgacgctt
3421 catcagaagg gcactggtgc aacggaaatt gctcatcagc tcagtattgc ccgctccacg
3481 gtttataaaa ttcttgaaga cgaaagggcc tcgtgatacg cctattttta taggttaatg
3541 tcatgataat aatggtttct tagacgtcag gtggcacttt tcggggaaat gtgcgcggaa
3601 cccctatttg tttatttttc taaatacatt caaatatgta tccgctcatg agacaataac
3661 cctgataaat gcttcaataa tattgaaaaa ggaagagtat gagtattcaa catttccgtg
3721 tcgcccttat tccctttttt gcggcatttt gccttcctgt ttttgctcac ccagaaacgc
3781 tggtgaaagt aaaagatgct gaagatcagt tgggtgcacg agtgggttac atcgaactgg
3841 atctcaacag cggtaagatc cttgagagtt ttcgccccga agaacgtttt ccaatgatga
3901 gcacttttaa agttctgcta tgtggcgcgg tattatcccg t
//
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验摘要: 腺相关病毒(AAV)是一种人细小病毒,目前因为能作为一种基因治疗载体而受到广泛关注。构建重组AAV(rAAV)涉及到用一个目的基因替换病毒基因组的大部分,然后将这个重组基因组包装到一个有感染性的病毒颗粒里。目前大多数生成rAAV的实验方案需要共转染一个载体质粒和一个表达病毒复制和结构基因的包装质粒到腺病毒(Ad)感染的培养细胞中。此方法的局限性包括(1) Ad辅助病毒污染rAAV,(2)rAAV的低产出,(3)生成有复制能力的AAV
H2 SO4 ):浓硫酸22.2ml、蒸馏水177.8ml。 7. 猪流行性腹泻(PED)抗原:PEDV猪胎肠原代细胞培养物,反复冻融,65℃ 30min灭活。最后以3 000 r/min离心30min,取上清分装,-20℃保存备用。抗原的蛋白浓度为300μg/ml。 8. 酶标兔抗猪抗体结合物:酶结合物效价为1∶10 000。 9. 被检猪血清:采自疫区猪和病猪。PEDV免疫猪血清及健猪血清分别用于阳性、阴性对照。 实验
摘要:腺相关病毒(AAV)是一种人细小病毒,目前因为能作为一种基因治疗载体而受到广泛关注。构建重组AAV(rAAV)涉及到用一个目的基因替换病毒基因组的大部分,然后将这个重组基因组包装到一个有感染性的病毒颗粒里。目前大多数生成rAAV的实验方案需要共转染一个载体质粒和一个表达病毒复制和结构基因的包装质粒到腺病毒(Ad)感染的培养细胞中。此方法的局限性包括(1) Ad辅助病毒污染rAAV,(2)rAAV的低产出,(3)生成有复制能力的AAV。在此报道中我们描述了新的辅助质粒(pH3和pH5),排
技术资料暂无技术资料 索取技术资料






